About Origin recognition complex subunit 5
Origin recognition complex subunit 5 (ORC5) is a protein
from Homo sapiens identified by UniProt accession
O43913, 435 residues long.
MolForge cross-references it against 0 known binders and
37 disease associations.
Target properties
| Protein name | Origin recognition complex subunit 5 |
| UniProt accession | O43913 |
| Gene | ORC5 |
| Organism | Homo sapiens |
| Length | 435 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (37)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.53
- alcohol consumption measurement · score 0.34
- brain volume measurement · score 0.29
- cortical surface area measurement · score 0.29
- cortical thickness · score 0.27
- glioblastoma multiforme · score 0.26
- brain measurement · score 0.23
- lung adenocarcinoma · score 0.23
- alcohol use disorder measurement · score 0.23
- bitter alcoholic beverage consumption measurement · score 0.22
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43913-F1 | alphafold | PREDICTED | 82.18 | — |
Amino-acid sequence (435 residues)
MPHLENVVLC RESQVSILQS LFGERHHFSF PSIFIYGHTA SGKTYVTQTL LKTLELPHVF VNCVECFTLR LLLEQILNKL NHLSSSEDGC STEITCETFN DFVRLFKQVT TAENLKDQTV YIVLDKAEYL RDMEANLLPG FLRLQELADR NVTVLFLSEI VWEKFRPNTG CFEPFVLYFP DYSIGNLQKI LSHDHPPEYS ADFYAAYINI LLGVFYTVCR DLKELRHLAV LNFPKYCEPV VKGEASERDT RKLWRNIEPH LKKAMQTVYL REISSSQWEK LQKDDTDPGQ LKGLSAHTHV ELPYYSKFIL IAAYLASYNP ARTDKRFFLK HHGKIKKTNF LKKHEKTSNH LLGPKPFPLD RLLAILYSIV DSRVAPTANI FSQITSLVTL QLLTLVGHDD QLDGPKYKCT VSLDFIRAIA RTVNFDIIKY LYDFL
Explore Origin recognition complex subunit 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets